Results 21 to 30 of about 202,640 (359)

Swiss Institutional Investors

, 2023
Abstract Institutional Investors, such as insurance companies, pension funds, real estate funds, and mutual funds, have become critically important players in the Swiss financial market. They channel capital from a multitude of investors, such as households, businesses, and the government, into asset classes like equities, debt, commodities ...
Henri B. Meier, John E. Marthinsen, Pascal A. Gantenbein, Samuel S. Weber   +3 more
openaire   +1 more source

How do Investors React Differently? Dynamic Analysis of Investor Ownership Movement: Evidence from Indonesia Listed Company

Journal of Management and Business Review
This study aims to dynamically analyze how global macroeconomic, domestic macroeconomic, and microeconomic variables influence the movements of foreign institutional, domestic institutional, and retail investors in Company X.
Syeren Amanda Ngangi, Yohanis Hans Kwee
doaj   +1 more source

Does institutional blockholders’ investment promote CSR spending? Evidence from Indian firms [PDF]

AJAR (Asian Journal of Accounting Research)
PurposeThis study aims to investigate the influence of institutional investors on corporate social responsibility (CSR) spending among Indian firms, focusing particularly on distinctions between domestic and foreign institutional ownership.
Srikanth Potharla, Balachandram Amirishetty, Hiranya Dissanayake   +2 more
doaj   +1 more source

Celebrity CEOs, digital transformation and firm performance in China: the moderating role of controlling shareholders and institutional investors

Frontiers in Psychology, 2023
Backgroundbusiness leaders’ social status significantly impacts companies’ strategic direction and performance. Digital transformation, an important tool for companies to enhance competitiveness and resilience, plays an important role in the relationship
Rui Wang, Dong Shao, Xinliang Han, Yinyue Li   +3 more
doaj   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Investigating Institutional Investors' Behaviours toward Cash Waqf Linked Sukuk (CWLS) using DTPB

International Journal of Islamic Economics and Finance, 2023
Cash Waqf Linked Sukuk (CWLS) is a newly developed social investment instrument to stimulate Indonesia's productive waqf movement. CWLS has numerous commercial and social benefits and worship values.
Dida Nurhaida, Farida Jasfar, Rifki Ismal, Acep Riana Jayaprawira   +3 more
doaj   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Mitigation of Moral Hazard and Adverse Selection in Venture Capital Financing: The Influence of the Country’s Institutional Setting [PDF]

, 2018
A venture capitalist (VC) needs to trade off benefits and costs when attempting to mitigate agency problems in their investor-investee relationship. We argue that signals of ventures complement the VC’s capacity to screen and conduct a due diligence ...
Agresti A., Akerlof G., Aldrich H. E., Ali‐Yrkkö J., Amit R., Amit R., Armstrong C., Barney J., Baum J. A., Bellavitis C., Bellavitis C., Bellavitis C., Bengtsson O., Bergemann D., Bienz C., Bingham C. B., Boeker W., Bohren O., Bollen K. A., Brander J. A., Bruderl J., Bruton G. D., Bruton G. D., Burchardt J., Busenitz L. W., Carter R. B., Chen K. C. W., Coff R. W., Cohen B. D., Connelly B. L., Cristiano Bellavitis, Cumming D., Cumming D., Cumming D., Cumming D., Cumming D., Cumming D., Cumming D., Cumming D., Cumming D. J., Davidson P., Devigne D., Dobrev S. D., Drover W., Dzidziso Samuel Kamuriwo, Edwards J. H., Ehrlich S. B., Filatotchev I., Franke N., Gao G., Garg S., Gilbert B., Gimeno J., Gompers P. A., Gorman M., Guth W. D., Hand J. R. M., Harrell F. E., Hart O., Hellmann T., Helmers C., Hsu D., Hsu D. H., Jain B. A., Janney J. J., Jensen M. C., Jia Y., Kanniainen V., Kaplan S., Kaplan S. N., Kaplan S. N., Kaplan S. N., Katila R., Kumar V., Kutner M. H., La Porta R., LaPorta R., LaPorta R., Lerner J., Lerner J., Levis M., Ljungqvist A., Long C., Manigart S., Manigart S., Mann R. J., Mas‐Colell A., Nahata R., Norton E., Norton E., Pisano G. P., Podolny J. M., Powell W. W., Sapienza H. J., Sapienza H. J., Schwienbacher A., Strätling R., Ulrich Hommel, Wang S., Wasserman N., Zajac E. J., Zimmerman M. A.   +101 more
core   +1 more source

ZNAČAJ I DJELOTVORNOST ŽIVOTNOG OSIGURANJA NA GOSPODARSKI RAZVOJ [PDF]

Zbornik Radova Ekonomskog Fakulteta u Istočnom Sarajevu, 2013
Insurance is a part of the major financial system of every state. Life insurance, with a primary characteristic of long-term savings, is an important product for institutional investors and important source for financing long-term investment.
Mira Pešić -Andrijić
doaj   +1 more source